Inogen
INGN
228 hedge funds and large institutions have $2.59B invested in Inogen in 2018 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 73 increasing their positions, 83 reducing their positions, and 21 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
48% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 21
4% more funds holding
Funds holding: 220 → 228 (+8)
3% more capital invested
Capital invested by funds: $2.5B → $2.59B (+$86.9M)
1.32% less ownership
Funds ownership: 100.68% → 99.36% (-1.3%)
12% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 83
50% less call options, than puts
Call options by funds: $4.58M | Put options by funds: $9.16M
Top Buyers
| 1 |
BlackRock
New York
|
+$13.6M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$10.4M |
| 3 |
Renaissance Technologies
New York
|
+$7.3M |
| 4 |
Goldman Sachs
New York
|
+$5.92M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.82M |
Top Sellers
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$22.3M |
| 2 |
Millennium Management
New York
|
-$16.6M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$11M |
| 4 |
Bank of New York Mellon
New York
|
-$9.41M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.28M |
INGN Hedge Fund Activity: Q1 2018 in Review
228 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q1 2018, worth a combined $2.59B — up 3.5% from $2.5B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new INGN positions and 21 closed out — a net gain of 10 holders — while 73 added to existing stakes and 83 trimmed.
The largest buyer was BlackRock, adding an estimated $13.6M. The largest seller was William Blair & Company, cutting an estimated $22.3M.
- 228 institutional investors held Inogen (INGN) as of Q1 2018, up from 220 in Q4 2017.
- Funds reported $2.59B of Inogen stock for Q1 2018, up 3.5% quarter-over-quarter.
- 31 funds opened new Inogen positions in Q1 2018 and 21 closed out, a net change of +10 holders.
- The largest Inogen buyer in Q1 2018 was BlackRock, an estimated $13.6M added.
- The largest Inogen seller in Q1 2018 was William Blair & Company, an estimated $22.3M sold.
Based on aggregated 13F filings for Q1 2018.